• Multiplexed ACE2 Profiling Reveals SARS-CoV-2 Variant Adapta

  2026-07-03

  This study introduces a high-throughput platform to assess how SARS-CoV-2 spike protein variants interact with diverse ACE2 receptor sequences. The findings map variant-specific shifts in receptor compatibility and provide a framework to investigate viral adaptation and cross-species transmission.

• Chronic E-64 Cathepsin Inhibition in Salt-Sensitive Hyperten

  2026-07-03

  This study systematically investigates whether chronic inhibition of cysteine cathepsins with E-64 alters the development of salt-sensitive hypertension and renal injury in Dahl rats. Contrary to expectations, E-64 had no significant effect on blood pressure or kidney damage, providing important clarification for researchers evaluating cysteine protease inhibition in cardiovascular and renal models.

• Oleic Acid (C18:1(9Z)): Optimizing Lipid Metabolism Research

  2026-07-02

  This article addresses common experimental challenges in lipid metabolism and cell viability workflows, demonstrating how Oleic Acid (SKU C4977) from APExBIO provides reliable, reproducible solutions. Using scenario-driven Q&A blocks, it synthesizes evidence-based recommendations for assay optimization and data interpretation with Oleic Acid.

• Sinapine Disrupts Gαq-PLCβ3 Axis to Ameliorate Cardiovascula

  2026-07-02

  This study uncovers how sinapine targets the EF hands domain of PLCβ3, selectively disrupting the Gαq-PLCβ3 interaction and thereby ameliorating aldosteronism and hypertension in animal models. The work highlights a mechanistically precise approach to modulating calcium signaling in cardiovascular disease, addressing key limitations of previous pan-PLC and Gαq inhibitors.

• EPA Omega-3: Mechanistic Leverage for Translational Success

  2026-07-01

  Translational researchers face a strategic inflection point: how to rationally select and implement lipid mediators like Eicosapentaenoic Acid (EPA) for maximum impact in cardiovascular and immunometabolic research. This article delivers a thought-leadership perspective blending state-of-the-art mechanistic findings, experimental guidance, and cross-domain insights—anchored by APExBIO’s high-purity EPA and the latest evidence on prostaglandin modulation and immune response. By connecting the dots across endothelial biology, lipid oxidation, and emerging immunological paradigms, we chart the path toward robust, reproducible results and next-generation applications.

• SmD2 Acetylation Regulates PARP Inhibitor Sensitivity in HCC

  2026-07-01

  This study uncovers how acetylation of the spliceosome core protein SmD2 modulates alternative exon usage and DNA repair in hepatocellular carcinoma (HCC), directly affecting cellular sensitivity to PARP inhibitors. These mechanistic insights suggest new therapeutic avenues for targeting DNA repair vulnerabilities in BRCA-proficient HCC.

• Substance P in Pain Transmission Research: Applied Protocols

  2026-06-30

  Unlock the full potential of the tachykinin neuropeptide Substance P in CNS and immune response studies with high-purity solutions and advanced spectral analysis. This guide details actionable workflows, troubleshooting tips, and recent breakthroughs that eliminate environmental interference, driving more robust neuroinflammation and pain research.

• Optimizing ARCA Capped mRNA Synthesis with HyperScribe Kit

  2026-06-30

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA workflows for vaccine development and functional genomics. Discover how this APExBIO kit enables robust, high-yield synthesis with unique protocol enhancements, real-world troubleshooting, and direct guidance from recent animal model breakthroughs.

• D-N-Acetylgalactosamine: Technical Protocols for Brain Glyco

  2026-06-29

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite used in biochemical and neurological research to analyze brain glycoproteins and glycosylation pathways. It is not suitable for protocols requiring ethanol solubility or long-term storage of solutions, making strict adherence to handling and storage specifications critical for reproducibility.

• qPCR Quantification of Moloney MLV in Mouse Cells: New Speci

  2026-06-29

  Choi et al. (2025) present a quantitative PCR assay that distinguishes exogenous Moloney Murine Leukemia Virus (M-MuLV) from endogenous retroviral sequences in mouse cells. This method offers rapid, sensitive, and scalable quantification of viral replication, addressing key limitations of traditional infectivity assays and enabling more precise retrovirus research.

• PreScission Protease (PSP): Tag Cleavage for Protein Purific

  2026-06-28

  PreScission Protease (PSP) addresses the need for precise removal of fusion tags from recombinant proteins without compromising protein integrity, especially during purification workflows. It is best suited to applications requiring specific cleavage at the Gln-Gly bond in low-temperature conditions and is not intended for broad-spectrum proteolysis or non-canonical cleavage sites.

• Oleic Acid (C18:1(9Z)) in Advanced Lipid Metabolism Research

  2026-06-27

  Oleic Acid (C18:1(9Z)) is pivotal for modeling lipid metabolism, inflammation, and cancer proliferation, offering robust, reproducible workflows in both in vitro and in vivo systems. This article outlines optimized handling protocols and troubleshooting insights, leveraging new breakthroughs for researchers using APExBIO’s high-purity reagent.

• Chemistry and Research Applications of Silybin from Milk Thi

  2026-06-26

  The review by Křen et al. presents a comprehensive account of silybin, the principal flavonolignan in milk thistle extract, detailing its chemical structure, stereochemistry, and derivatization strategies. These advances have clarified silybin’s role as a research tool in oxidative stress, hepatocellular carcinoma, and metabolic regulation, and have informed the development of robust, reproducible experimental workflows.

• Thiothixene: Bridging Antipsychotic Mechanisms and Macrophag

  2026-06-26

  This thought-leadership article explores the multifaceted research potential of Thiothixene, a typical antipsychotic agent, as both a neuropharmacological modulator and a robust tool for enhancing macrophage efferocytosis. It offers mechanistic insights, evidence-based protocol recommendations, and strategic guidance for translational researchers seeking to leverage Thiothixene’s unique dual action in neuropsychiatric and immunological studies. Drawing on clinical pharmacokinetics, competitive landscape analysis, and novel immunomodulatory pathways, the piece positions APExBIO’s Thiothixene as a catalyst for cross-disciplinary breakthroughs.

• VE-821 ATR Kinase Inhibitor: Driving Next-Gen DNA Repair Res

  2026-06-25

  Explore how VE-821, a potent ATR kinase inhibitor, is redefining DNA repair pathway research and radiosensitization strategies. This article delivers a profound, practical guide for leveraging VE-821 in advanced assays, with unique insights into cross-talk between DNA damage response and epigenetic regulation.

16450 records 1/1097 page Next 12345 下5页 Last page